- Home
- LENZ vs MCN Comparison
LENZ vs MCN Comparison
Compare LENZ & MCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LENZ | MCN |
|---|---|---|
| Founded | 2019 | 2004 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.8M | 112.7M |
| IPO Year | 2021 | 2004 |
Fundamental Metrics
Financial Performance| Metric | LENZ | MCN |
|---|---|---|
| Price | $4.04 | $5.46 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $14.83 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 68.6K |
| Earning Date | 10-28-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.96% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,088,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $125.50 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.80 | $5.18 |
| 52 Week High | $32.13 | $6.20 |
Technical Indicators
Market Signals| Indicator | LENZ | MCN |
|---|---|---|
| Relative Strength Index (RSI) | 57.53 | 59.68 |
| Support Level | $3.60 | $5.25 |
| Resistance Level | $6.11 | $5.69 |
| Average True Range (ATR) | 0.38 | 0.06 |
| MACD | 0.14 | 0.02 |
| Stochastic Oscillator | 77.71 | 95.74 |
Price Performance
Historical ComparisonAbout LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
About MCN Madison Covered Call & Equity Strategy Fund
XAI Madison Equity Premium Income Fund is an investment management company. The Fund invests in an actively managed equity portfolio comprised of individual stocks and covered call options. The Fund's primary investment objective is to provide high level of current income and gains, with a secondary objective of capital appreciation.